The Effect of "Persons With Disability Friendly Nursing Education Program"

February 28, 2022 updated by: Ilknur Aydin Avci, Ondokuz Mayıs University

The Effect of "Persons With Disability Friendly Nursing Education Program" on Nursing Students' Emphatic Tendency and Perception of Caring Competency

The purpose of this research; The aim of this study is to measure the effect of the Persons With Disability Friendly Nursing Education Program developed based on the Story Theory on the empathic tendencies of senior nursing students towards persons with disability and their perceptions of competence of senior nursing students to care for persons with disability. In the research, a multi-stage evaluation design from mixed method research will be used. Focus group interviews will be conducted before and after the program in the qualitative dimension of the research, while the randomized controlled double-blind pretest-posttest control group experimental design will be used in the quantitative dimension. The data of the research will be collected in the Department of Nursing of the Faculty of Health Sciences of Ondokuz Mayis University in Samsun, Turkey.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The purpose of this research; The aim of this study is to measure the effect of the Persons With Disability Friendly Nursing Education Program developed based on the Story Theory on the empathic tendencies of senior nursing students towards persons with disability and their perceptions of competence of senior nursing students to care for persons with disability. In the research, a multi-stage evaluation design from mixed method research will be used. Focus group interviews will be conducted before and after the program in the qualitative dimension of the research, while the randomized controlled double-blind pretest-posttest control group experimental design will be used in the quantitative dimension. The data of the research will be collected in the Department of Nursing of the Faculty of Health Sciences of Ondokuz Mayis University in Samsun, Turkey. The program will be applied to nursing senior students in this department. Before the training program, focus group discussions will be held with nursing students, and the content of the training program will be created. The pre-test data of the study will be collected using an introductory information form questioning sociodemographic characteristics, Efficacy Perceptions Form for Caring for Persons with Disabilities, Empathic Tendency Scale and Achievement Test. A 2-week " Persons With Disability Friendly Nursing Education Program" will be applied to the experimental group. After the program, focus group discussions will be held with the students in the experimental group, and the program will be evaluated. Post-tests will be applied to the experimental and control groups 3 months after the program. Descriptive statistics, paired t-test, chi-square, Mann-Whitney U, Wilcoxon analysis will be used in the analysis of the data. Content analysis will be used in qualitative data analysis.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
114

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Samsun, Turkey, 55105
        • Güven Soner

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being senior nursing student

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: "Persons With Disability Friendly Nursing Education Program"
Intervention group after determining the students according to the research criteria, they were randomized into intervention and control groups. Firstly, pre-tests were applied to the students in the experimental group.
Behavioral: "Persons With Disability Friendly Nursing Education Program"
Persons With Disability Friendly Nursing Education Program developed based on the Story Theory, 2 weeks program
No Intervention: non-"Persons With Disability Friendly Nursing Education Program"
Firstly, Pre-tests were applied to the students in the control group. No intervention was applied to this group. Posttests were made 3 months after pre-test.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Empathic Tendency Scale
Time Frame: 3 month
The Empathic Tendency Scale was developed by Dokmen (1988). The scale consists of 20 items, which are answered with a five-point rating (1= totally contradictory, 5= totally appropriate). 12 items of the scale consist of positive statements and 8 items of negative statements. Negative statements are reverse coded. The pupae that can be taken from the scale are between 20 and 100 points. High scores mean high empathic tendency. Dokmen (1988) found the reliability coefficient of the scale as .72 in his study.
3 month
Form of Perceptions for Caring for Persons with Disabilities
Time Frame: 3 month
Form of Perceptions for Caring for Persons with Disabilities will be evaluated with a 20-item scale developed by researchers in line with the literature and scored between 0-10 (0, I don't feel adequate at all; 10, I feel very competent). Students will express their perceptions of competence by scoring from 0 to 10 on this scale. Higher scores indicate higher perceptions of caregiving competence.
3 month
Program Achievement Test
Time Frame: 3 month
The Achievement Test is a test consisting of 20 closed-ended questions with 5 answer options, developed by the researchers in line with the information in the training program. The increase in the scores obtained from the achievement test indicates that the perception of efficacy towards caregiving increases. In the test, each correct answer corresponds to "1" point and each wrong answer corresponds to "0" point.
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Ondokuz Mayıs University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: İlknur Aydın Avci, Prof. Dr., Ondokuz Mayıs University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2022

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 1, 2022

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 1, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 16, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 16, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 25, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 15, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 28, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2020/386

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings